SAYER KEVIN R — SEC insider filings
SEC reporting owner CIK 1286858. 41 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2020-09-11 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 132 legs across 30 filings — 678,442 shares, $122,812,704 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 39,521 shares @ $362.12 ($14,311,309) in DEXCOM INC, filed 2021-01-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| DEXCOM INC (DXCM) | Executive Chair, Director | 39 | — | 132 legs · 678,442 sh · $122,812,704 | 23 |
| Guardant Health, Inc. (GH) | Director | 2 | — | — | 1 |
Insider filings — SAYER KEVIN R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Guardant Health, Inc. (GH) | Grant/award (A): 3,149 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 3 | Guardant Health, Inc. (GH) | Holdings only — no transactions reported | EDGAR |
| 2026-08-24 | 4 | DEXCOM INC (DXCM) | Sale (S): 19,308 @ $89.71 · Sale (S): 7,351 @ $90.78 · Sale (S): 97 @ $91.41 | EDGAR |
| 2026-07-21 | 4 | DEXCOM INC (DXCM) | Sale (S): 26,756 @ $76.32 | EDGAR |
| 2026-07-07 | 4 | DEXCOM INC (DXCM) | Sale (S): 26,756 @ $72 | EDGAR |
| 2026-05-26 | 4 | DEXCOM INC (DXCM) | Sale (S): 26,759 @ $72 | EDGAR |
| 2026-03-10 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 32,749 @ $0 · Tax withholding (F): 32,498 @ $68.10 | EDGAR |
| 2026-02-02 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 71,218 @ $0 · Tax withholding (F): 34,257 @ $73.36 | EDGAR |
| 2025-03-14 | 4 | DEXCOM INC (DXCM) | Sale (S): 32,498 @ $70.38 | EDGAR |
| 2025-03-11 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 85,490 @ $0 | EDGAR |
| 2025-01-30 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 68,503 @ $0 · Sale (S): 33,359 @ $86.91 | EDGAR |
| 2024-04-10 | 4 | DEXCOM INC (DXCM) | Sale (S): 27,272 @ $137.96 · Sale (S): 22,361 @ $138.71 | EDGAR |
| 2024-03-14 | 4 | DEXCOM INC (DXCM) | Sale (S): 29,675 @ $134.41 · Sale (S): 12,470 @ $131.47 · Sale (S): 14,993 @ $132.43 · Sale (S): 20,930 @ $133.55 · Sale (S): 2,939 @ $134.07 | EDGAR |
| 2024-03-11 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 51,692 @ $0 | EDGAR |
| 2024-01-17 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 72,709 @ $0.00 · Sale (S): 37,325 @ $123.63 | EDGAR |
| 2023-04-05 | 4 | DEXCOM INC (DXCM) | Sale (S): 5,995 @ $113.83 · Sale (S): 11,218 @ $114.39 · Sale (S): 3,599 @ $115.70 | EDGAR |
| 2023-03-14 | 4 | DEXCOM INC (DXCM) | Disposition to issuer (D): 17,302 @ $111.40 · Disposition to issuer (D): 9,141 @ $111.40 · Disposition to issuer (D): 11,047 @ $111.40 | EDGAR |
| 2023-03-10 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 54,422 @ $0.00 | EDGAR |
| 2023-03-02 | 4 | DEXCOM INC (DXCM) | Sale (S): 31,203 @ $109.83 · Sale (S): 7,261 @ $110.41 | EDGAR |
| 2023-01-31 | 4 | DEXCOM INC (DXCM) | Sale (S): 47,693 @ $106.06 · Sale (S): 9,151 @ $106.65 | EDGAR |
| 2023-01-24 | 4 | DEXCOM INC (DXCM) | Sale (S): 45,607 @ $105.75 | EDGAR |
| 2023-01-20 | 4 | DEXCOM INC (DXCM) | Gift (G): 10,000 @ $0 · Grant/award (A): 90,720 @ $0 | EDGAR |
| 2022-03-17 | 4 | DEXCOM INC (DXCM) | Sale (S): 445 @ $405.84 · Sale (S): 405 @ $407 · Sale (S): 150 @ $407.60 · Sale (S): 400 @ $408.89 · Sale (S): 445 @ $410 · Sale (S): 405 @ $411.25 · +4 more | EDGAR |
| 2022-03-10 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 16,251 @ $0.00 · Disposition to issuer (D): 3,149 @ $406.06 · Disposition to issuer (D): 4,473 @ $406.06 · Disposition to issuer (D): 2,363 @ $406.06 | EDGAR |
| 2022-02-15 | 4 | DEXCOM INC (DXCM) | Sale (S): 3,000 @ $418.04 | EDGAR |
| 2022-01-20 | 4 | DEXCOM INC (DXCM) | Sale (S): 3,000 @ $438.81 · Grant/award (A): 38,586 @ $0 · Sale (S): 19,674 @ $435.06 | EDGAR |
| 2021-12-17 | 4 | DEXCOM INC (DXCM) | Sale (S): 200 @ $528.06 · Sale (S): 148 @ $529.78 · Sale (S): 25 @ $530.44 · Sale (S): 300 @ $531.87 · Sale (S): 100 @ $532.92 · Sale (S): 500 @ $534.84 · +8 more | EDGAR |
| 2021-11-16 | 4 | DEXCOM INC (DXCM) | Gift (G): 3,000 @ $0 · Sale (S): 222 @ $644.59 · Sale (S): 250 @ $645.01 · Sale (S): 200 @ $646.58 · Sale (S): 1,350 @ $647.92 · Sale (S): 878 @ $649.02 · +2 more | EDGAR |
| 2021-10-18 | 4 | DEXCOM INC (DXCM) | Sale (S): 999 @ $545.84 · Sale (S): 1,246 @ $546.71 · Sale (S): 939 @ $547.76 · Sale (S): 681 @ $548.71 · Sale (S): 120 @ $549.95 · Sale (S): 851 @ $550.93 · +3 more | EDGAR |
| 2021-09-16 | 4 | DEXCOM INC (DXCM) | Sale (S): 400 @ $536.49 · Sale (S): 1,050 @ $537.45 · Sale (S): 413 @ $538.63 · Sale (S): 700 @ $539.59 · Sale (S): 640 @ $540.92 · Sale (S): 1,252 @ $541.88 · +2 more | EDGAR |
| 2021-09-13 | 4 | DEXCOM INC (DXCM) | Sale (S): 35 @ $541.27 · Sale (S): 2,982 @ $541.36 | EDGAR |
| 2021-05-05 | 4 | DEXCOM INC (DXCM) | Sale (S): 2,543 @ $376.33 · Sale (S): 487 @ $376.98 · Sale (S): 248 @ $377.97 · Sale (S): 126 @ $378.99 · Sale (S): 500 @ $382.48 · Sale (S): 300 @ $384.91 · +1 more | EDGAR |
| 2021-04-07 | 4 | DEXCOM INC (DXCM) | Sale (S): 1,475 @ $365.67 · Sale (S): 3,567 @ $366.84 · Sale (S): 1,179 @ $367.41 | EDGAR |
| 2021-03-12 | 4 | DEXCOM INC (DXCM) | Sale (S): 14,044 @ $362.92 | EDGAR |
| 2021-03-10 | 4 | DEXCOM INC (DXCM) | Gift (G): 10,000 @ $0 · Grant/award (A): 13,445 @ $0.00 · Sale (S): 306 @ $356.94 · Sale (S): 400 @ $358.75 · Sale (S): 550 @ $359.82 · Sale (S): 700 @ $361.02 · +3 more | EDGAR |
| 2021-02-03 | 4 | DEXCOM INC (DXCM) | Sale (S): 800 @ $373.44 · Sale (S): 400 @ $374.47 · Sale (S): 2,323 @ $376.05 · Sale (S): 1,406 @ $376.91 · Sale (S): 1,350 @ $378.11 · Sale (S): 1,095 @ $379.20 · +1 more | EDGAR |
| 2021-01-14 | 4 | DEXCOM INC (DXCM) | Sale (S): 428 @ $359.68 · Sale (S): 39,521 @ $362.12 · Sale (S): 1,600 @ $350.95 · Sale (S): 2,331 @ $352.41 · Sale (S): 1,100 @ $353.39 · Sale (S): 500 @ $354.94 · +3 more | EDGAR |
| 2021-01-12 | 4 | DEXCOM INC (DXCM) | Grant/award (A): 75,910 @ $0 | EDGAR |
| 2020-12-03 | 4 | DEXCOM INC (DXCM) | Sale (S): 1,557 @ $319.76 · Sale (S): 3,327 @ $321.19 · Sale (S): 3,970 @ $322.24 · Sale (S): 3,119 @ $323.45 · Sale (S): 1,260 @ $324.38 | EDGAR |
| 2020-10-30 | 4 | DEXCOM INC (DXCM) | Sale (S): 600 @ $333.63 · Sale (S): 2,910 @ $335.53 · Sale (S): 2,428 @ $336.43 · Sale (S): 1,676 @ $337.50 · Sale (S): 1,200 @ $339.93 · Sale (S): 1,430 @ $341.55 · +8 more | EDGAR |
| 2020-09-11 | 4 | DEXCOM INC (DXCM) | Sale (S): 6,897 @ $398.30 · Sale (S): 3,068 @ $398.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1286858 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs